POT1 Gene Melanoma Cutaneous Malignant Familial Type 10 Susceptibility to Genetic Test
Test Name: POT1 Gene Melanoma Cutaneous Malignant Familial Type 10 Susceptibility to Genetic Test
Components: Blood or Extracted DNA or One drop Blood on FTA Card
Price: 4400.0 AED
Report Delivery: 3 to 4 Weeks
Method: NGS Technology
Test Type: Cancer
Doctor: Oncologist
Test Department: Genetics
Pre Test Information: Clinical History of Patient who is going for POT1 Gene Melanoma, Cutaneous Malignant, Familial Type 10, Susceptibility to NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with POT1 Gene Melanoma, Cutaneous Malignant, Familial Type 10, Susceptibility to NGS Genetic DNA Test gene POT1
Test Details: The POT1 gene is associated with cutaneous malignant melanoma, which is a type of skin cancer. Specifically, the familial type 10 refers to a specific genetic variant in the POT1 gene that increases the susceptibility to developing this type of melanoma within families. NGS (Next-Generation Sequencing) genetic testing is a method used to analyze multiple genes simultaneously and identify any variations or mutations that may be present. In the case of the POT1 gene, NGS testing can help determine if there are any genetic changes or mutations that may increase the risk of developing cutaneous malignant melanoma. This type of genetic testing can be useful for individuals with a family history of melanoma or those who are concerned about their risk. By identifying any genetic variations, individuals can take appropriate measures for early detection, prevention, and management of the disease. It is important to note that genetic testing should be done under the guidance of a healthcare professional who can provide appropriate counseling and interpretation of the results.
Test Name | POT1 Gene Melanoma cutaneous malignant familial type 10 susceptibility to Genetic Test |
---|---|
Components | |
Price | 4400.0 AED |
Sample Condition | Blood or Extracted DNA or One drop Blood on FTA Card |
Report Delivery | 3 to 4 Weeks |
Method | NGS Technology |
Test type | Cancer |
Doctor | Oncologist |
Test Department: | Genetics |
Pre Test Information | Clinical History of Patient who is going for POT1 Gene Melanoma, cutaneous malignant, familial type 10, susceptibility to NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with POT1 Gene Melanoma, cutaneous malignant, familial type 10, susceptibility to NGS Genetic DNA Test gene POT1 |
Test Details |
The POT1 gene is associated with cutaneous malignant melanoma, which is a type of skin cancer. Specifically, the familial type 10 refers to a specific genetic variant in the POT1 gene that increases the susceptibility to developing this type of melanoma within families. NGS (Next-Generation Sequencing) genetic testing is a method used to analyze multiple genes simultaneously and identify any variations or mutations that may be present. In the case of the POT1 gene, NGS testing can help determine if there are any genetic changes or mutations that may increase the risk of developing cutaneous malignant melanoma. This type of genetic testing can be useful for individuals with a family history of melanoma or those who are concerned about their risk. By identifying any genetic variations, individuals can take appropriate measures for early detection, prevention, and management of the disease. It is important to note that genetic testing should be done under the guidance of a healthcare professional who can provide appropriate counseling and interpretation of the results. |